Summary & Overview
HCPCS G9189: Beta-blocker Therapy Prescribed or Currently Taken
HCPCS Level II code G9189 denotes documented beta-blocker therapy — either prescribed or actively taken. Nationally, this code is used to capture medication management and treatment adherence for conditions commonly managed with beta-blockers, such as hypertension, heart failure, and ischemic heart disease. Accurate use of G9189 supports clinical documentation, care coordination, and quality measurement related to cardiovascular therapy.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for beta-blocker therapy, the typical sites of service where G9189 is recorded, and the payer landscape for coverage and claims processing. The publication outlines benchmarks for code use, relevant policy considerations affecting billing and documentation, and operational implications for ambulatory and specialty practices.
The summary provides practical clarity on when G9189 applies and what organizations should expect regarding coding capture and reporting. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9189 represents beta-blocker therapy prescribed or currently being taken. This code indicates the presence of an active prescription or ongoing use of beta-adrenergic blocking agents.
-
Service type: Medication therapy management / prescription documentation
-
Typical site of service: Outpatient clinic, primary care office, cardiology clinic, or other ambulatory settings where medication reconciliation and chronic therapy management occur.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with a history of hypertension and prior myocardial infarction presents to a primary care clinic for routine cardiovascular risk management. He reports episodes of palpitations and exertional dyspnea. The clinician documents ongoing beta-blocker therapy prescribed and confirms the patient is currently taking the medication as directed. Medication reconciliation is performed, vitals are recorded (including heart rate and blood pressure), and the clinician assesses tolerance, side effects, and adherence. The encounter may occur in an outpatient clinic, cardiology office, or an ambulatory primary care setting. Relevant workflow steps include medication reconciliation, focused cardiovascular history, review of recent labs (electrolytes, renal function), assessment of contraindications (e.g., asthma exacerbation, bradycardia), and documentation that beta-blocker therapy is prescribed or currently being taken for chronic management of ischemic heart disease, heart failure with reduced ejection fraction, or rate control for atrial fibrillation. This service may be billed when the primary documented action for the visit is confirmation or prescription of beta-blocker therapy (G9189).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work is substantially greater than typically required for documentation or clinical complexity related to medication management. |